Category:

Regulatory

Award, fellowship & grant

Business and Market Strategy

Regulatory

Lupin Receives U.S. FDA Approval for Interchangeable Ranibizumab Biosimilar Ranluspec

Regulatory

FDA Launches One-Day Inspection Pilot to Enhance Risk-Based Oversight

Regulatory

FDA Novel Drug Approvals 2026 Q1: Full List & Insights

book/virender-singh-molecules-mentors-mindsets/

Regulatory

Biocon Biologics Marks U.S. Milestone: First Interchangeable Biosimilar Approval

Regulatory

FDA Novel Drug Therapy Approvals for 2025 | Quarter 2

Regulatory

FDA Approves Linvoseltamab for Advanced Multiple Myeloma Treatment

Industry

FDA Novel Drug Therapy Approvals for 2025 | Quarter 1

Industry

Biocon Biologics Secures U.S. FDA Approval for Jobevne

Industry

Major Breakthrough in Antibiotics targeting urinary tract infections

Industry

CAR T-Cell Therapy for Relapsed/Refractory B-Cell Malignancies

Regulatory

NABL Approves Shoolini Life Sciences Food Testing Facility

Regulatory

FDA Approves First Rapid-Acting Insulin Biosimilar, Merilog

book/virender-singh-molecules-mentors-mindsets/

Applications Open for Prime Minister Research Chair (PMRC) Scheme 2026

June 5, 2026

Artificial Heart Pumps Help Save Three Teenagers Before Heart Transplants at Narayana Health

June 5, 2026

Lupin Receives U.S. FDA Approval for Interchangeable Ranibizumab Biosimilar Ranluspec

June 5, 2026

Antara Launches Integrative Medicine Clinic for Chronic Disease Care in Gurugram

June 5, 2026

Beyond Junk DNA: Sudhakaran Prabakaran on the Dark Genome and Humanity’s Hidden Genetic Potential

June 5, 2026